|
業務類別
|
-- |
|
業務概覽
|
Idorsia Ltd is a biopharmaceutical company engaged in discovering, developing, and commercializing of medicines for unmet medical needs. The company is a biotech hub of Europe specialized in the discovery and development of small molecules, to provide new therapeutic options. The company focuses on multiple therapeutic areas which include the central nervous system, cardiovascular disorders, immunological disorders, and orphan diseases. The company's development compounds target a number of different diseases such as Resistant Hypertension, lupus, insomnia, Cerebral vasospasm, and Fabry disease. Geographically, it derives revenue from Switzerland. |
| 公司地址
| Hegenheimermattweg 91, Allschwil, CHE, 4123 |
| 電話號碼
| +41 588441010 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.idorsia.com |
| 員工數量
| 487 |
| Mr. Bart Filius, M.B.A. |
Independent Director |
25/02/2026 |
| Mr. Jean-Paul Clozel |
Chairman of the Board |
25/02/2026 |
| Mr. Sandesh Mahatme, L.L.M. |
Independent Director |
25/02/2026 |
| Dr. Mathieu Simon |
Vice Chairman of the Board and Lead Independent Director |
25/02/2026 |
| Ms. Srishti Gupta, M.D. |
Independent Director |
25/02/2026 |
|
|
|
|
